<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang G</submitter><funding>NIGMS NIH HHS</funding><pagination>13575</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5648759</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>TFPI-2 has recently been recognized as a tumor suppressor, which not only plays a fundamental role in modulation of ECM integrity, but also involves the regulation of many oncogenes. In this study, we investigated the potential mechanism of TFPI-2 in the suppression of breast cancer growth and invasion. We showed that, with either over-expression of TFPI-2 or after treatment with exogenous rTFPI-2, breast cancer cells exhibited reduced proliferation and invasion. We demonstrated that in addition to being secreted, TFPI-2 was also distributed throughout the cytoplasm and nucleus. Nuclear localization of TFPI-2 contributed to inhibition of MMP-2 mRNA expression, which could be reversed after the nuclear localization signal was deleted. In the nucleus, interaction of TFPI-2 with Ap-2? attenuated the binding of AP-2? to the MMP-2 promoter, therefore reducing the transcriptional activity of the gene. Our results suggest that one of the mechanisms by which TFPI-2 inhibits breast cancer cell invasion could be via the regulation of MMP-2 gene transcription.</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells.</pubmed_title><pmcid>PMC5648759</pmcid><funding_grant_id>R01 GM057071</funding_grant_id><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Singer RH</pubmed_authors><pubmed_authors>Gu W</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Zeng Y</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells.</name><description>TFPI-2 has recently been recognized as a tumor suppressor, which not only plays a fundamental role in modulation of ECM integrity, but also involves the regulation of many oncogenes. In this study, we investigated the potential mechanism of TFPI-2 in the suppression of breast cancer growth and invasion. We showed that, with either over-expression of TFPI-2 or after treatment with exogenous rTFPI-2, breast cancer cells exhibited reduced proliferation and invasion. We demonstrated that in addition to being secreted, TFPI-2 was also distributed throughout the cytoplasm and nucleus. Nuclear localization of TFPI-2 contributed to inhibition of MMP-2 mRNA expression, which could be reversed after the nuclear localization signal was deleted. In the nucleus, interaction of TFPI-2 with Ap-2? attenuated the binding of AP-2? to the MMP-2 promoter, therefore reducing the transcriptional activity of the gene. Our results suggest that one of the mechanisms by which TFPI-2 inhibits breast cancer cell invasion could be via the regulation of MMP-2 gene transcription.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2021-03-14T08:56:57Z</modification><creation>2019-03-27T02:59:25Z</creation></dates><accession>S-EPMC5648759</accession><cross_references><pubmed>29051606</pubmed><doi>10.1038/s41598-017-14148-8</doi></cross_references></HashMap>